Tribenzor (Daiichi Sankyo, Inc.)
Welcome to the PulseAid listing for the Tribenzor drug offered from Daiichi Sankyo, Inc.. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Daiichi Sankyo, Inc. |
| NON-PROPRIETARY NAME: | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide |
| SUBSTANCE NAME: | OLMESARTAN MEDOXOMIL; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-07-31 |
| END MARKETING DATE: | 0000-00-00 |
Tribenzor HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tribenzor from Daiichi Sankyo, Inc. |
| LABELER NAME: | Daiichi Sankyo, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20; 5; 12.5(mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2010-07-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65597-114_ef0729da-0645-42fd-9c27-ad722fe88ef1 |
| PRODUCT NDC: | 65597-114 |
| APPLICATION NUMBER: | NDA200175 |
Other OLMESARTAN MEDOXOMIL; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
